US Market Report for Orthopedic Bone Graft Substitutes 2017 - MedCore

  • ID: 4085811
  • Report
  • Region: United States
  • 589 pages
  • iData Research
15 % OFF
until Oct 31st 2018
1 of 4

FEATURED COMPANIES

  • Anika Therapeutics
  • Bioventus
  • DePuy Synthes
  • Ferring Pharmaceuticals
  • Genzyme
  • Integra LifeSciences
  • MORE

General Report Contents

- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends

- Market Drivers & Limiters for each chapter segment

- Competitive Analysis for each chapter segment

- Section on recent mergers & acquisitions

As of 2016, the synthetic bone grafts accounted for the largest portion of the market followed by the demineralized bone matrix (DBM) grafts. Market growth has been supported by the strong adoption of the BMP growth factor market, which is represented by Medtronic’s INFUSE® product. Furthermore, the fast growing cellular allograft market has benefited the bone graft substitute market by allowing greater osteogenic properties with the use of stem cells. The recent resurgence of growth in the cheaper allograft material market has pushed DBM prices lower in order to stay competitive.

The synthetic bone graft segment surpassed the DBM segment due to both a higher ASP and stronger unit sales growth in the U.S. market. Synthetic grafts are more commonly used in spinal surgeries rather than applications involving larger volumes, as with fracture repair. These large volume indications are the reason that cheaper options, such as allograft bone, play an important role in the market.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Anika Therapeutics
  • Bioventus
  • DePuy Synthes
  • Ferring Pharmaceuticals
  • Genzyme
  • Integra LifeSciences
  • MORE

Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Markets Included
Key Report Updates
Version History

1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

2. Disease Overview
2.1 Basic Anatomy
2.1.1 Osteology And Musculoskeletal System
2.2 Disease Pathology And Disorders
2.2.1 General Diagnostic
2.2.2 Osteoporosis
2.2.3 Osteoarthritis
2.2.4 Indication For Bone Graft Procedure
2.2.5 Indication For Cartilage Repair
2.2.6 Degenerative Disc Disease
2.3 Patient Demographics
2.3.1 General Statistics

3. Product Assessment
3.1 Product Portfolios
3.1.1 Bone Graft Substitutes
3.2 Regulatory Issues And Recalls
3.2.1 Bone Graft Substitutes
3.3 Clinical Trials
3.3.1 Bone Graft Substitutes

4. Orthopedic Bone Graft Substitute Market
4.1 Introduction
4.1.1 Units Per Procedure By Indication
4.2 Market Overview
4.2.1 Bone Graft Substitute Market By Material
4.2.2 Bone Graft Substitute Market By Indication
4.3 Market Analysis And Forecast
4.3.1 Total Orthopedic Bone Graft Substitute Market
4.3.2 Bone Graft Substitute Market By Material
4.3.2.1 Total Allograft Bone Graft Substitute Market
4.3.2.2 Allograft Bone Graft Substitute Market By Indication
4.3.2.2.1 Spine
4.3.2.2.2 Trauma
4.3.2.2.3 Large Joint Reconstruction
4.3.2.2.4 Foot Reconstruction
4.3.2.2.5 Craniomaxillofacial
4.3.2.2.6 Oncology
4.3.2.3 Total Demineralized Bone Matrix Market
4.3.2.4 Demineralized Bone Matrix Market With And Without Carriers
4.3.2.5 Demineralized Bone Matrix Market By Indication
4.3.2.5.1 Spine
4.3.2.5.2 Trauma
4.3.2.5.3 Large Joint Reconstruction
4.3.2.5.4 Foot Reconstruction
4.3.2.5.5 Craniomaxillofacial
4.3.2.5.6 Oncology
4.3.2.6 Total Synthetic Bone Graft Substitute Market
4.3.2.7 Synthetic Bone Graft Substitute Market By Indication
4.3.2.7.1 Spine
4.3.2.7.2 Trauma
4.3.2.7.3 Large Joint Reconstruction
4.3.2.7.4 Foot Reconstruction
4.3.2.7.5 Craniomaxillofacial
4.3.2.7.6 Oncology
4.3.3 Bone Graft Substitute Market By Indication
4.3.3.1 Spine
4.3.3.1.1 Cervical Spine
4.3.3.1.2 Thoracolumbar Spine
4.3.3.2 Trauma
4.3.3.2.1 Non-Union Trauma
4.3.3.2.2 Fresh Fracture Trauma
4.3.3.3 Large Joint Reconstruction
4.3.3.3.1 Hip Large Joint Reconstruction
4.3.3.3.2 Knee Large Joint Reconstruction
4.3.3.4 Foot Reconstruction
4.3.3.5 Craniomaxillofacial
4.3.3.6 Oncology
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.1.1 Allograft Bone Graft Substitute Market
4.4.1.2 Demineralized Bone Matrix Bone Graft Substitute Market
4.4.1.3 Synthetic Bone Graft Substitute Market
4.4.2 Market Limiters
4.4.2.1 Allograft Bone Graft Substitute Market
4.4.2.2 Demineralized Bone Matrix Bone Graft Substitute Market
4.4.2.3 Synthetic Bone Graft Substitute Market
4.5 Competitive Market Share Analysis

List of Charts

Chart 1 1: Orthopedic Biomaterials Market By Segment, U.S., 2013 - 2023
Chart 1 2: Orthopedic Biomaterials Market Overview, U.S., 2016 & 2023
Chart 4 1: Orthopedic Bone Graft Substitute Market By Material, U.S., 2013 - 2023
Chart 4 2: Orthopedic Bone Graft Substitute Market Breakdown By Material, U.S., 2016
Chart 4 3: Orthopedic Bone Graft Substitute Market Breakdown By Material, U.S., 2023
Chart 4 4: Orthopedic Bone Graft Substitute Market By Indication, U.S., 2013 - 2023
Chart 4 5: Orthopedic Bone Graft Substitute Market Breakdown By Indication, U.S., 2016
Chart 4 6: Orthopedic Bone Graft Substitute Market Breakdown By Indication, U.S., 2023
Chart 4 7: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 8: Total Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 9: Allograft Bone Graft Substitute Market By Indication, U.S., 2013 - 2023
Chart 4 10: Total Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 11: Cervical Spine Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 12: Thoracolumbar Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 13: Total Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 14: Non-Union Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 15: Fresh Fracture Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 16: Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 17: Hip Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 18: Knee Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 19: Foot Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 20: Craniomaxillofacial Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 21: Oncology Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 22: Total Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 23: Demineralized Bone Matrix Market By Indication, U.S., 2013 - 2023
Chart 4 24: Total Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 25: Cervical Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 26: Thoracolumbar Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 27: Total Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 28: Non-Union Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 29: Fresh Fracture Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 30: Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 31: Hip Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 32: Knee Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 33: Foot Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 34: Craniomaxillofacial Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 35: Oncology Demineralized Bone Matrix Market, U.S., 2013 - 2023
Chart 4 36: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 37: Synthetic Bone Graft Substitute Market By Indication, U.S., 2013 - 2023
Chart 4 38: Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 39: Cervical Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 40: Thoracolumbar Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 41: Total Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 42: Non-Union Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 43: Fresh Fracture Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 44: Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 45: Hip Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 46: Knee Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 47: Foot Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 48: Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 49: Oncology Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 50: Spine Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 51: Cervical Spine Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 52: Thoracolumbar Spine Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 53: Total Trauma Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 54: Non-Union Trauma Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 55: Fresh Fracture Trauma Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 56: Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 57: Hip Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 58: Knee Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 59: Foot Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 60: Craniomaxillofacial Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 61: Oncology Bone Graft Substitute Market, U.S., 2013 - 2023
Chart 4 62: Leading Competitors, Orthopedic Bone Graft Substitute Market, U.S., 2016

List of Figures

Figure 1 1: Orthopedic Biomaterials Market Share Ranking By Segment, U.S., 2016 (1 Of 2)
Figure 1 2: Orthopedic Biomaterials Market Share Ranking By Segment, U.S., 2016 (2 Of 2)
Figure 1 3: Companies Researched In This Report, U.S., 2016
Figure 1 4: Factors Impacting The Orthopedic Biomaterials Market By Segment, U.S. (1 Of 2)
Figure 1 5: Factors Impacting The Orthopedic Biomaterials Market By Segment, U.S. (2 Of 2)
Figure 1 6: Recent Events In The Orthopedic Biomaterials Market, U.S., 2013 - 2016
Figure 1 7: Orthopedic Biomaterials Markets Covered, U.S., 2016 (1 Of 2)
Figure 1 8: Orthopedic Biomaterials Markets Covered, U.S., 2016 (2 Of 2)
Figure 1 9: Orthopedic Biomaterials Markets Covered, U.S., 2016(1 Of 3)
Figure 3 1: Bone Graft Substitutes Products By Company (1 Of 3)
Figure 3 2: Bone Graft Substitutes Products By Company (2 Of 3)
Figure 3 3: Bone Graft Substitutes Products By Company (3 Of 3)
Figure 3 4: Class 2 Device Recall Endobon Xenograft Granules
Figure 3 5: Class 2 Device Recall Accell Evo3C Demineralized Bone Matrix Putty
Figure 3 6: Class 2 Device Recall Allofuse Dbm Putty 5Cc
Figure 3 7: Class 2 Device Recall Microfuse Bone Void Filler
Figure 3 8: Class 2 Device Recall Grafton
Figure 3 9: Class 2 Device Recall Optimum Expanse
Figure 3 10: Class 2 Device Recall Integra Mozaik
Figure 3 11: An Acdf Multi-Center Study Using Vivigen Cellular Bone Matrix
Figure 3 12: Cerament Treatment Of Fracture Defects (Certify)
Figure 3 13: Synthetic Bone Graft Substitute Vs. Autologous Spongiosa In Revision Anterior Cruciate Ligament Reconstruction
Figure 3 14: Assessment Of Nanoss Bioactive 3D In The Posterolateral Spine
Figure 3 15: Attrax® Putty Vs. Autograft In Xlif®
Figure 3 16: Evaluation Of Fusion Rate Using K2M Vesuvius® Demineralized Fibers With K2M Everest® Spinal System
Figure 3 17: Clinical Evaluation Of Genex® Ds In Instrumented Posterolateral Fusion
Figure 3 18: Efficacy And Safety Of Surgifill™ On Spinal Fusion
Figure 3 19: Evaluation Of Dtrax Graft In Patients With Cervical Degenerative Disc Disease
Figure 3 20: Comparison Of Nanoss Bioactive With Autograft And Bone Marrow Aspirate To Autograft In The Posterolateral Spine
Figure 3 21: Evaluation Of Fusion Rate Of Anterior Cervical Discectomy And Fusion (Acdf) Using Cervios Chronos™ And Bonion™
Figure 4 1: Units Per Procedure By Indication, Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 2: Orthopedic Bone Graft Substitute Market By Material, U.S., 2013 - 2023 (Us$M)
Figure 4 3: Orthopedic Bone Graft Substitute Market By Indication, U.S., 2013 - 2023 (Us$M)
Figure 4 4: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 5: Total Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 6: Allograft Bone Graft Substitute Market By Indication, U.S., 2013 - 2023
Figure 4 7: Total Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 8: Cervical Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 9: Thoracolumbar Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 10: Total Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 11: Non-Union Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 12: Fresh Fracture Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 13: Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 14: Hip Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 15: Knee Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 16: Foot Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 17: Craniomaxillofacial Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 18: Oncology Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 19: Total Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 20: Demineralized Bone Matrix Market (With Carriers), U.S., 2013 - 2023
Figure 4 21: Demineralized Bone Matrix Market (Without Carriers), U.S., 2013 - 2023
Figure 4 22: Demineralized Bone Matrix Market By Indication, U.S., 2013 - 2023
Figure 4 23: Total Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 24: Cervical Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 25: Thoracolumbar Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 26: Total Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 27: Non-Union Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 28: Fresh Fracture Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 29: Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 30: Hip Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 31: Knee Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 32: Foot Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 33: Craniomaxillofacial Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 34: Oncology Demineralized Bone Matrix Market, U.S., 2013 - 2023
Figure 4 35: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 36: Synthetic Bone Graft Substitute Market By Indication, U.S., 2013 - 2023
Figure 4 37: Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 38: Cervical Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 39: Thoracolumbar Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 40: Total Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 41: Non-Union Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 42: Fresh Fracture Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 43: Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 44: Hip Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 45: Knee Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 46: Foot Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 47: Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 48: Oncology Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 49: Spine Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 50: Cervical Spine Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 51: Thoracolumbar Spine Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 52: Total Trauma Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 53: Non-Union Trauma Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 54: Fresh Fracture Trauma Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 55: Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 56: Hip Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 57: Knee Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 58: Foot Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 59: Craniomaxillofacial Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 60: Oncology Bone Graft Substitute Market, U.S., 2013 - 2023
Figure 4 61: Drivers And Limiters, Orthopedic Bone Graft Substitute Market, U.S., 2016
Figure 4 62: Leading Competitors, Orthopedic Bone Graft Substitute Market, U.S., 2016
Figure 6 1: Press Release Summary

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic
  • Genzyme
  • DePuy Synthes
  • Anika Therapeutics
  • Ferring Pharmaceuticals
  • Stryker
  • NuVasive
  • Bioventus
  • Zimmer Biomet
  • Integra LifeSciences
  • RTI Surg
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll